Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.58 |
| ▸ | CA2 | P00918 | 4/20 | 0.58 |
| ▸ | CA7 | P43166 | 3/20 | 0.58 |
| ▸ | CA9 | Q16790 | 3/20 | 0.58 |
| ▸ | CA12 | O43570 | 2/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL196734 | 0.87 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL29387155 | 0.87 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL518108 | 0.86 | CA1 (0.44) | CA1CA2CA7CA9CA12 | |
| SCHEMBL170725 | 0.85 | CA1 (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL17039548 | 0.84 | KCNK3 (0.44) | CA1CA2CA7CA9CA12 | |
| SCHEMBL13347755 | 0.83 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1728265 | 0.83 | CA12 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2090612 | 0.83 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1118854 | 0.83 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL16368 | 0.83 | TP53 (0.64) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115894184-B | Method for preparing di (2, 6-dimethoxy phenyl) triethylene glycol | 黎明化工研究设计院有限责任公司 | 2024-07-05 | — | — | CN | claimed |
| CN-115894184-A | Method for preparing di (2, 6-dimethoxyphenyl) triethylene glycol | 黎明化工研究设计院有限责任公司 | 2023-04-04 | — | — | CN | claimed |
| US-20260078141-A1 | 8-FLUORO-4-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE, BIOLOGICAL STERILIZATION INDICATOR INCLUDING THE SAME AND ITS USE IN A METHOD OF DETERMINING EFFICACY OF A STERILIZATION PROCESS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4698520-A1 | RAF-MEK PROTEIN COMPLEX MODULATORS AND METHODS OF USE THEREOF | Gandeeva Therapeutics, Inc. (US) | 2026-02-25 | — | — | EP | disclosed |
| US-12486301-B2 | 8-fluoro-4-alkylumbelliferyl α-D-glucopyranoside, biological sterilization indicator including the same and its use in a method of determining efficacy of a sterilization process | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-12-02 | — | — | US | disclosed |
| WO-2024220708-A1 | RAF-MEK PROTEIN COMPLEX MODULATORS AND METHODS OF USE THEREOF | GANDEEVA THERAPEUTICS, INC. (US) | 2024-10-24 | — | — | WO | disclosed |
| US-20240307577-A1 | CHLORINATED 4'-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE AND METHOD OF ASSESSING EFFICACY OF A STERILIZATION PROCESS INCLUDING THE SAME | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-09-19 | — | — | US | disclosed |
| CN-115894184-B | Method for preparing di (2, 6-dimethoxy phenyl) triethylene glycol | 黎明化工研究设计院有限责任公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-4373830-A1 | CHLORINATED 4'-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE AND METHOD OF ASSESSING EFFICACY OF A STERILIZATION PROCESS INCLUDING THE SAME | Solventum Intellectual Properties Company (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-4034544-B1 | 8-FLUORO-4-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE, BIOLOGICAL STERILIZATION INDICATOR INCLUDING THE SAME AND ITS USE IN A METHOD OF DETERMINING EFFICACY OF A STERILIZATION PROCESS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-15 | — | — | EP | disclosed |
| CN-115894184-A | Method for preparing di (2, 6-dimethoxyphenyl) triethylene glycol | 黎明化工研究设计院有限责任公司 | 2023-04-04 | — | — | CN | disclosed |
| US-6229055-B1 | SYNTHESIS OF FLUORINATED RESORCINOL WHICH IS USEFUL IN THE PREPARATION OF FLUORINATED FLUORESCEIN AND RHODOL DYES SUITABLE FOR USE AS TRACERS, LABELS, OR INTERMEDIATES | MOLECULAR PROBES, INC. | 2001-05-08 | — | — | US | disclosed |
| US-6162931-A | Fluorinated xanthene derivatives | MOLECULAR PROBES, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| EP-1019453-A1 | AROMATIC-SUBSTITUTED XANTHENE DYES | THE PERKIN-ELMER CORPORATION (US) | 2000-07-19 | — | — | EP | disclosed |
| EP-1013629-A1 | Preparation process of fluorine subsituted aromatic compound | Mitsui Chemicals, Inc. (JP) | 2000-06-28 | — | — | EP | disclosed |
| US-6008379-A | USEFUL AS FLUORESCENT DYES FOR LABELING | THE PERKIN-ELMER CORPORATION (US) | 1999-12-28 | — | — | US | disclosed |
| EP-0740359-B1 | Non-aqueous electrolyte secondary cell having shuttle agent | SONY CORP (JP) | 1999-08-04 | — | — | EP | disclosed |
| WO-1999016832-A1 | AROMATIC-SUBSTITUTED XANTHENE DYES | THE PERKIN-ELMER CORPORATION (US) | 1999-04-08 | — | — | WO | disclosed |
| CN-1138219-A | Non aqueous electroryte secondary cell with shuttle agent | SONY CORP (JP) | 1996-12-18 | — | — | CN | disclosed |
| EP-0740359-A1 | Non-aqueous electrolyte secondary cell having shuttle agent | SONY CORPORATION (JP) | 1996-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078141-A1 | 8-FLUORO-4-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE, BIOLOGICAL STERILIZATION INDICATOR INCLUDING THE SAME AND ITS USE IN A METHOD OF DETERMINING EFFICACY OF A STERILIZATION PROCESS | ALPG, UNG, UGDH | CA1 1263/4885CA2 2668/4885CA7 1049/4885 |
| US-12486301-B2 | 8-fluoro-4-alkylumbelliferyl α-D-glucopyranoside, biological sterilization indicator including the same and its use in a method of determining efficacy of a sterilization process | ALPG, UNG, UGDH | CA1 836/4885CA2 2691/4885CA7 850/4885 |
| US-20240307577-A1 | CHLORINATED 4'-ALKYLUMBELLIFERYL ALPHA-D-GLUCOPYRANOSIDE AND METHOD OF ASSESSING EFFICACY OF A STERILIZATION PROCESS INCLUDING THE SAME | UGGT1, UGT1A7, UGT1A3 | CA1 2498/4885CA2 3945/4885CA7 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.